Acrivon Therapeutics ACRV Ratios (2021-2026)

NASDAQ ACRV
$2.20 -0.19 (-7.95%)
At close: Aug 20, 2026 · 4:00 PM EDT
Ratios Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets Average (Quarter) 134.47M175.71M165.12M155.57M144.68M129.39M175.55M222.63M205.64M186.47M167.47M151.94M137.51M118.77M103.46M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -2.13-1.51-33.15-0.69-0.80-1.33-70.18-1.87-4.28-2.94-49.91-5.49-56.06-39.61-19.14-7.63-8.25
Times Interest Earned (Quarter) -2.13-1.51-33.15-0.69-0.80-1.33-70.18-1.87-4.28-2.94-49.91-5.49-56.06-39.61-19.14-7.63-8.25
Valuation
Enterprise Value (Quarter) -3.61M-99.60M-90.77M-83.86M-76.82M-127.75M-120.21M-150.95M-142.09M-127.46M-109.97M-180.54M-187.45M-179.48M-149.63M-137.42M-129.25M-118.58M-97.74M-89.96M
Return Ratios
Return on Capital Employed (Quarter) -25.52%-23.43%-31.27%-38.28%-51.08%-58.48%-46.45%-41.05%-47.34%-53.89%-61.29%-64.90%-69.03%-76.45%-85.17%
Return on Assets (Quarter) 0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%